Abstract
Obesity at diagnosis of breast cancer is associated with higher all-cause mortality and treatment-associated toxicities. We
evaluated the association between parity and obesity in the Ella study, a population of Mexican and Mexican–American breast cancer patients with high parity. Obesity outcomes included body
mass index (BMI) ≥30 kg/m2, waist circumference (WC) ≥35 in (88 cm), and waist-to-hip-ratio (WHR) ≥0.85. Prevalence of obesity ([BMI] ≥ 30 kg/m2) was 38.9 %. For WC, the multivariate odds ratio (OR) (95 % confidence interval [CI]) for having WC ≥ 35 inches in women
with ≥4 pregnancies relative to those with 1–2 pregnancies was 1.59 (1.01–2.47). Higher parity (≥4 pregnancies) was non-significantly
associated with high BMI (OR = 1.10; 95 % CI 0.73–1.67). No positive association was observed for WHR. Our results suggest
WC is independently associated with high parity in Hispanic women and may be an optimal target for post-partum weight loss
interventions.
evaluated the association between parity and obesity in the Ella study, a population of Mexican and Mexican–American breast cancer patients with high parity. Obesity outcomes included body
mass index (BMI) ≥30 kg/m2, waist circumference (WC) ≥35 in (88 cm), and waist-to-hip-ratio (WHR) ≥0.85. Prevalence of obesity ([BMI] ≥ 30 kg/m2) was 38.9 %. For WC, the multivariate odds ratio (OR) (95 % confidence interval [CI]) for having WC ≥ 35 inches in women
with ≥4 pregnancies relative to those with 1–2 pregnancies was 1.59 (1.01–2.47). Higher parity (≥4 pregnancies) was non-significantly
associated with high BMI (OR = 1.10; 95 % CI 0.73–1.67). No positive association was observed for WHR. Our results suggest
WC is independently associated with high parity in Hispanic women and may be an optimal target for post-partum weight loss
interventions.
- Content Type Journal Article
- Category Original Paper
- Pages 1-10
- DOI 10.1007/s10903-012-9649-8
- Authors
- María Elena Martínez, Moores UCSD Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, #0901, La Jolla, CA 92093-0901, USA
- Erika Pond, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
- Betsy C. Wertheim, Arizona Cancer Center, Tucson, AZ, USA
- Jesse N. Nodora, Moores UCSD Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, #0901, La Jolla, CA 92093-0901, USA
- Elizabeth T. Jacobs, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
- Melissa Bondy, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA
- Adrian Daneri-Navarro, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
- Maria Mercedes Meza-Montenegro, Instituto Tecnológico de Sonora, Ciudad Obregón, Sonora, Mexico
- Luis Enrique Gutierrez-Millan, Universidad de Sonora, Hermosillo, Sonora, Mexico
- Abenaa Brewster, Department of Clinical Cancer Prevention, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
- Ian K. Komenaka, Department of Surgery, Maricopa Medical Center, Phoenix, AZ, USA
- Patricia Thompson, Arizona Cancer Center, Tucson, AZ, USA
- Journal Journal of Immigrant and Minority Health
- Online ISSN 1557-1920
- Print ISSN 1557-1912